Combining circulating tumor cell and circulating cell-free DNA analyses broadens clinical applicability of liquid biopsy in high grade serous tubo-ovarian carcinoma. - Cavina B; Corrà S; Coadă CA; De Luise M; Lemma S; Coluccelli S; De Leo A; Di Costanzo S; Mezzapesa F; Girolimetti G; De Iaco P; Porcelli AM; et al. (Experimental hematology & oncology, 2026)